A Prognostic Risk Model for Breast Cancer Integrating Migrasome and Tumor Microenvironment Features to Predict Immunological Characteristics.
A computationally derived and externally validated prognostic model for BRCA based on migrasome and tumor microenvironment features successfully stratifies patients into groups with divergent clinical outcomes, immune profiles, and therapeutic responses, providing insights into BRCA heterogeneity and prognosis.